相关实验视频

Updated: Jun 26, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

在Trypanosoma cruzi感染期间,甲福明可以通过巨细胞调节改善CD8+ T细胞反应和寄生病控制

Ruth Eliana Baigorri^1,2, María Belén Brugo^1,2, Florencia Hellriegel^1,2

¹Centro de Investigaciones en Bioquímica Clínica e Inmunología, Consejo Nacional de Investigaciones Científicas y Técnicas, Córdoba, Argentina.

Journal of leukocyte biology

|September 26, 2025

概括

在Trypanosoma cruzi感染中,甲胺 (Metf) 治疗减少了有害的炎症,并改善了CD8+ T细胞的反应. 这种方法平衡了寄生虫控制与免疫功能,为查加斯病提供了潜在的好处.

科学领域:

免疫学免疫学免疫学
寄生虫学的寄生虫学
药理学药理学是指药理学的学科.

背景情况:

杆菌感染会引发巨细胞炎症和CD8+ T细胞功能障碍.
过度的炎症和反应性氧物种会损害T细胞的反应,并导致查加斯病的病理.
氧化 (NO) 和调节性T细胞在感染期间抑制CD8+T细胞活性.

研究的目的:

调查甲胺 (Metf) 调节巨细胞激活和改善Trypanosoma cruzi感染中的免疫反应的潜力.
评估Metf对CD8+T细胞功能和与查加斯病相关的炎症的影响.

主要方法:

从被Metf.感染的小鼠中对腹膜巨细胞 (PEMs) 的ex vivo治疗.
在体外共培养治疗的PEM与CD8+T细胞.
在体内给感染的小鼠注射Metf.
分析炎症标志物,NO生产,细胞因子水平,寄生病,T细胞增殖和心脏炎症.

主要成果:

在PEM中,Metf降低了可诱导的NO合成酶,NO的产生,以及促炎性细胞因子 (IL-1β,TNF,IL-6).
Metf增加了IL-12水平,增强了CD8+ T细胞的增殖和干扰素-γ的产生.
在体内,Metf降低了寄生病,改善了CD8+T细胞功能,降低了T细胞受体化,降低了调控性T细胞频率,并减轻了心脏炎症.

结论:

甲胺有效调节巨细胞激活,平衡寄生虫控制和免疫介导的组织损伤在Trypanosoma cruzi感染.
甲治疗通过减少抑制机制,如NO生产和调节性T细胞活性来增强CD8+T细胞的反应.
甲胺作为一种治疗策略,有望通过减轻炎症和增强抗寄生虫免疫力来改善查加斯病的结果.

关键词:

蒂·克鲁兹·克鲁兹 (T. Cruzi) 是一个著名的演员.在CD8 T细胞中,CD8 T细胞巨细胞是什么?巨细胞是什么?这是一种元炎症.甲胺是一种甲胺.

更多相关视频

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs

Published on: June 23, 2022

Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi

Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi

Published on: May 12, 2023

相关概念视频

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...